{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "MYCN",
                "DNA Alteration": "c.131C>T",
                "GeneMutation": "p.P44L Frameshift-GOF",
                "VariantAlleleFraction": "25.0%"
            },
            {
                "Gene": "DICER1",
                "DNA Alteration": "c.5437G>A",
                "GeneMutation": "p.D1810H Stopgain-LOF",
                "VariantAlleleFraction": "2.01%"
            },
            {
                "Gene": "TLR8",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.N515H Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "4.13%"
            },
            {
                "Gene": "MTOR",
                "DNA Alteration": "c.5664C>A",
                "GeneMutation": "p.G1954R Frameshift-LOF",
                "VariantAlleleFraction": "9.31%"
            },
            {
                "Gene": "ZEB2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.H1038R Frameshift-GOF",
                "VariantAlleleFraction": "1.33%"
            },
            {
                "Gene": "ALDH2",
                "DNA Alteration": "c.1510G>A",
                "GeneMutation": "p.E504K Nonsense-GOF",
                "VariantAlleleFraction": "2.46%"
            }
        ],
        "Germline": [
            {
                "Gene": "MYCN",
                "DNA Alteration": "c.131_132delinsTT",
                "GeneMutation": "p.P44L Spliceregionvariant-LOF",
                "Condition": "myself"
            },
            {
                "Gene": "CTNNB1",
                "DNA Alteration": "c.101G>T",
                "GeneMutation": "p.G34R Frameshift-LOF",
                "Condition": "choice"
            }
        ]
    }
}